A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)
Clinical trial NCT04278820 · UNKNOWN
Trial details
- NCT number
- NCT04278820
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-20
- Primary completion
- 2022-11-30
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.